IVERIC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IVERIC and buy or sell other stocks, ETFs, and their options commission-free!

About ISEE

IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. 

CEO
Glenn P. Sblendorio, MBA
CEOGlenn P. Sblendorio, MBA
Employees
Employees
Headquarters
Parsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded
2007
Founded2007
Employees
Employees

ISEE Key Statistics

Market cap
5.51B
Market cap5.51B
Price-Earnings ratio
-22.69
Price-Earnings ratio-22.69
Dividend yield
Dividend yield
Average volume
6.52M
Average volume6.52M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$39.99
52 Week high$39.99
52 Week low
$9.39
52 Week low$9.39

Stock Snapshot

IVERIC(ISEE) stock is priced at $39.95, giving the company a market capitalization of 5.51B. It carries a P/E multiple of -22.69.

On 2025-12-15, IVERIC(ISEE) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for IVERIC(ISEE) stock has reached 0, versus its average volume of 6.52M.

The stock's 52-week range extends from a low of $9.39 to a high of $39.99.

The stock's 52-week range extends from a low of $9.39 to a high of $39.99.

People also own

Based on the portfolios of people who own ISEE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.